GASTROMIRO

This brand name is authorized in Austria, Estonia, Ireland, UK.

Active ingredients

The drug GASTROMIRO contains one active pharmaceutical ingredient (API):

1
UNII JR13W81H44 - IOPAMIDOL
 

Iopamidol is contrast medium belonging to the new generation of non-ionic compound whose solubility is due to the presence of hydrophilic substitutes in the molecule. This results in a solution of low osmollity when compared with ionic media.
 
Read more about Iopamidol

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 GASTROMIRO Solution for oral or rectal administration MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
V08AB04 Iopamidol V Various → V08 Contrast media → V08A X-ray contrast media, iodinated → V08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media
Discover more medicines within V08AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1026605, 1079096, 1079108
GB Medicines & Healthcare Products Regulatory Agency 399375, 399380, 399382

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈